Yahoo
Brussels - Delayed Quote EUR

Financière de Tubize SA (TUB.BR)

185.00 +11.00 (+6.32%)
At close: 5:35:25 PM GMT+2
Chart Range Bar
Loading chart for TUB.BR
  • Previous Close 174.00
  • Open 175.10
  • Bid --
  • Ask --
  • Day's Range 174.60 - 184.70
  • 52 Week Range 168.10 - 250.50
  • Volume 25,493
  • Avg. Volume 17,809
  • Market Cap (intraday) 8.235B
  • Beta (5Y Monthly) 0.40
  • PE Ratio (TTM) 83.71
  • EPS (TTM) 2.21
  • Earnings Date (est.) Aug 3, 2026
  • Forward Dividend & Yield 1.08 (0.62%)
  • Ex-Dividend Date May 7, 2026
  • 1y Target Est 286.00

Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium. It focuses on the discovery and development of treatments for patients suffering from diseases affecting immune or central nervous system. The company was founded in 1928 and is based in Brussels, Belgium.

www.financiere-tubize.be

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/20/2026, which may include dividends or other distributions. Benchmark is BEL 20 (^BFX) .

YTD Return

TUB.BR
10.79%
BEL 20 (^BFX)
10.69%

1-Year Return

TUB.BR
21.02%
BEL 20 (^BFX)
11.73%

3-Year Return

TUB.BR
184.98%
BEL 20 (^BFX)
67.63%

5-Year Return

TUB.BR
108.01%
BEL 20 (^BFX)
33.15%

Analyst Insights

View More

Analyst Price Targets

286.00
286.00 Average
185.00 Current
286.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
As of 9/23/2026
  • Market Cap

    7.93B

  • Enterprise Value

    7.88B

  • Trailing P/E

    80.60

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    3.99

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    80.09

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -0.10%

  • Return on Equity (ttm)

    5.02%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    98.41M

  • Diluted EPS (ttm)

    2.21

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    49.9M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -2.61M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: